NCT07715565
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- West China Hospital, Chengdu, Sichuan 610000 Chengdu, China
Clinical trial condition
Molecular Targeted Therapy
Explore clinical trials studying Molecular Targeted Therapy. Study availability and eligibility vary by location and protocol.
5 public trials
0 recruiting studies
Molecular Targeted Therapy trial results
Not Yet Recruiting
Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer
NCT06848439
- Conditions
- Head and Neck Neoplasms, Immunotherapy, Molecular Targeted Therapy, +6 more
- Locations
-
- Affiliated Stomatological Hospital of Nanjing Medical University Nanjing, Jiangsu, China
Not Yet Recruiting
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
NCT06523049
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- West China Hospital Chengdu, Sichuan, China
Completed
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
NCT04642547
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai, Shanghai Municipality, China
Active, Not Recruiting
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
NCT04521153
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- 180 Fenglin Road Shanghai, Shanghai Municipality, China